ArticlemedRxiv : the preprint server for health sciences2025
The impact of ancestry on performance of type 1 diabetes genetic risk scores: high discrimination performance is maintained in African ancestry populations, but population specific thresholds may improve risk prediction.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
20 authors.
Funding
Abstract
objectiveGenetic risk scores (GRSs) for type 1 diabetes (T1D) may assist T1D classification and prediction but are often developed from European populations. To improve health outcomes, it is important to understand the performance and utility of GRSs in diverse ancestry populations. RESEARCH DESIGN AND
methodsWe assessed performance of three previously published T1D GRSs in differentiating people with and without Type 1 diabetes in African (with/without T1D=194/235), European (n=1109/125), and Hispanic (266/170) ancestry populations in the USA, and from Cameroon and Uganda (n=144/5001). The assessed GRSs were developed from European ancestry populations (GRS1, GRS2) and from an African ancestry population (AAGRS).
resultsThe discriminative power, as measured by the area under the receiver operating characteristic curve (AUC), for GRS2 and AAGRS were equivalent on the African ancestry populations, and both outperformed the GRS1: the AUCs produced by the GRS2, AAGRS and GRS1 on Uganda/Cameroon data were 0.882 (0.845-0.914), 0.874 (0.838-0.907) and 0.816 (0.772-0.857) respectively. GRS2 outperformed the AAGRS and GRS1 on Hispanic and European populations. The GRS2 distributions varied by population, with lower average scores for African populations. If the same GRS2 risk thresholds of 11.5 were set for European and African populations, the sensitivities were 0.91 and 0.53, respectively.
conclusionsThe GRS2 produced similar or improved discriminative power across the populations but the AAGRS matched performance on African ancestry participants with fewer single nucleotide polymorphisms. Varying GRS2 risk thresholds may be required for different populations due to the divergent distributions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.